METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB

METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB

Provided herein is are methods of reducing exacerbations of asthma in an asthma patient, comprising administering to the patient an effective amount of the anti-interleukin-5 receptor (IL- 5R) antibody benralizumab or an antigen-binding fragment thereof. L'invention concerne des procédés pour r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RAIBLE, DONALD G, ROSKOS, LORIN, WANG, BING, WARD, CHRISTINE
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Provided herein is are methods of reducing exacerbations of asthma in an asthma patient, comprising administering to the patient an effective amount of the anti-interleukin-5 receptor (IL- 5R) antibody benralizumab or an antigen-binding fragment thereof. L'invention concerne des procédés pour réduire des exacerbations d'asthme chez un patient atteint d'asthme, comprenant l'administration au patient d'une quantité efficace de benralizumab d'anticorps de récepteur anti-interleukine-5 (IL-5R) ou d'un fragment de liaison d'antigène de ce dernier.